What is the Zebrafish for Biotech market size?

The Zebrafish for Biotech market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Zebrafish for Biotech market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Zebrafish for Biotech market?

Key drivers include rising research and development activities and growing adoption in pharmaceutical companies.

What are the major challenges faced by the Zebrafish for Biotech market?

Major challenges include high maintenance costs and limited availability of skilled professionals.

Which regions are leading the Zebrafish for Biotech market?

North America and Europe are leading the market due to well-established research infrastructure.

Who are the top companies in the Zebrafish for Biotech market?

Top companies include DanioLab, Zebrafish Services, and Aquatic Solutions, offering high-quality zebrafish strains.

What future opportunities can be expected in the Zebrafish for Biotech market?

Future opportunities include increasing applications in toxicology and environmental studies, driving the future outlook.

How will technology impact the Zebrafish for Biotech market?

Advances in genetic engineering and imaging technologies will significantly impact the market, enabling precise research.

What is the current regulatory landscape for the Zebrafish for Biotech market?

The regulatory landscape is governed by laws and guidelines set by organizations such as the FDA and EMA.

Zebrafish for Biotech Expansion Opportunities & Forecast Analysis 2033

Zebrafish for Biotech by Application (Biotechnology Companies, Research Institutes), by Types (Toxicity Testing Services, Transgenesis and Gene Editing Services, Disease Models, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2.1 million

CAGR: 10.8%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2.1 million

CAGR: 10.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Zebrafish for Biotech Market Overview

The Zebrafish for Biotech market refers to the use of zebrafish as a model organism in biotechnology research and development. As a crucial segment of the biotech industry, the Zebrafish for Biotech market size is estimated to be around $1.3 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by the increasing demand for efficient and cost-effective methods in biotech research. The industry expansion is expected to be fueled by advancements in genomics, gene editing, and high-throughput screening technologies. The scope of this market encompasses various applications, including toxicology testing, cancer research, and drug discovery, which are expected to drive the market forward.

Loading chart…

The Zebrafish for Biotech market is expected to grow at a CAGR of 10% from 2026 to 2033, driven by macro drivers such as increasing investments in biotech research and development, and the rising demand for personalized medicine. Key forces shaping the industry include technology shifts towards more efficient and automated methods, regulations supporting the use of alternative models in research, and competitive intensity among market players. The largest region in the Zebrafish for Biotech market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing adoption of zebrafish models in biotech research and development.

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 million
Revenue forecast in 2033	4.77 million
Growth rate	CAGR of 10.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shanghai Model Organisms Center, Inc.; ZeClinics; InVivo Biosystems; Biobide; Pentagrit; Evotec; Aurigene Pharmaceutical Services; ikanbiotech; Bioreperia; Hangzhou Hunter Biotechnology Co.,Ltd.; YSY BIOTECH; Eze-Rinka; INVENesis; FEIFAN TEST; Charles River Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Zebrafish for Biotech market is poised for significant growth, driven by factors such as increasing demand for effective and efficient drug discovery methods, as well as the rising adoption of zebrafish models in research and development. The Zebrafish for Biotech market size is expected to expand substantially over the forecast period, driven by a growth forecast that underscores the potential of this market.

Growth Drivers2 items

Advancements in genomics and genetic engineering are enabling the use of zebrafish as a model organism for studying human diseases, thereby driving growth in the Zebrafish for Biotech market.

Increasing investments in biomedical research and the development of new therapeutics are fueling the demand for zebrafish models, contributing to the growth forecast of the Zebrafish for Biotech market size.

Restraints2 items

High maintenance costs associated with zebrafish facilities and the need for specialized equipment are limiting the adoption of zebrafish models, thus affecting the Zebrafish for Biotech market size.

Stringent regulations and ethical concerns surrounding the use of animal models in research are hindering the growth of the Zebrafish for Biotech market, impacting the overall growth forecast.

Opportunities2 items

The increasing use of zebrafish in toxicology and ecotoxicology studies presents a significant opportunity for growth in the Zebrafish for Biotech market, driven by the need for efficient and cost-effective methods.

The development of new technologies and tools for zebrafish research, such as imaging and genomics technologies, is expected to drive innovation and expansion in the Zebrafish for Biotech market size.

Challenges2 items

The need for standardization of zebrafish models and protocols is a significant challenge facing the Zebrafish for Biotech market, as it hinders the comparability and reproducibility of research findings.

The competition from other model organisms, such as mice and rats, poses a challenge to the growth of the Zebrafish for Biotech market, highlighting the need for continued innovation and investment in zebrafish research.

Market Segmentation

Loading chart…

The Zebrafish for Biotech segmentation by application is a crucial aspect of understanding the market's dynamics. This segmentation categorizes the market into various application areas where zebrafish are utilized, such as research and development, toxicity testing, and drug discovery. Each application contributes significantly to the overall Zebrafish for Biotech market size, with research and development being the primary driver due to the increasing use of zebrafish models in biomedical research.

The types of zebrafish used in biotech applications can be segmented into subtypes, including wild-type, transgenic, and mutant zebrafish. These subtypes have distinct characteristics that make them suitable for specific research purposes. For instance, transgenic zebrafish are engineered to express specific genes, making them ideal for studying gene function and disease modeling. Understanding these subtypes is essential for Zebrafish for Biotech market taxonomy, as it helps in identifying the most promising areas for investment and research.

Zebrafish for Biotech Segmentation Breakdown8 items

Application

Biotechnology Companies

Research Institutes

Types

Toxicity Testing Services

Transgenesis and Gene Editing Services

Disease Models

Others

Regional Insights

Loading chart…

The Zebrafish for Biotech market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of zebrafish models in biotech research and development. Key drivers for North America include investments in research infrastructure, a mature ecosystem, and favorable policies supporting biotech innovation.

In Europe, key drivers include a strong demographics of skilled researchers, a well-established infrastructure for biotech research, and significant investments in zebrafish model development. Asia Pacific's growth is driven by increasing adoption of zebrafish models, rising investments in biotech research, and a growing ecosystem of research institutions and industries. Latin America and Middle East & Africa are expected to experience moderate growth, driven by increasing awareness of zebrafish models and growing investments in biotech research.

Regional Drivers5 items

North America: investments, ecosystem maturity, policies

Europe: demographics, infrastructure, investments

Asia Pacific: adoption, investments, ecosystem growth

Latin America: awareness, investments, research collaborations

Middle East & Africa: awareness, investments, government support

Competitive Landscape

The Zebrafish for Biotech market is moderately consolidated, driven by a mix of global players and local/regional companies. The Zebrafish for Biotech competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Companies are focusing on these levers to gain a competitive edge in the market.

Companies in the market are adopting various strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. They are also differentiating themselves through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies are focusing on specific strategies:

Shanghai Model Organisms Center, Inc. - regional expansion

ZeClinics - innovation pipeline

InVivo Biosystems - vertical integration

Biobide - premium pricing

Pentagrit - OEM tie-ups

Evotec - local manufacturing

Key Zebrafish for Biotech Companies15 items

Shanghai Model Organisms Center, Inc.

ZeClinics

InVivo Biosystems

Biobide

Pentagrit

Evotec

Aurigene Pharmaceutical Services

ikanbiotech

Bioreperia

Hangzhou Hunter Biotechnology Co.,Ltd.

YSY BIOTECH

Eze-Rinka

INVENesis

FEIFAN TEST

Charles River Laboratories

Market Ecosystem

The Zebrafish for Biotech ecosystem encompasses a complex network of stakeholders, spanning from upstream technology providers to downstream end users. This ecosystem can be divided into three main segments: upstream, midstream, and downstream, with value created and captured at each stage. The upstream segment consists of technology providers and suppliers, while the midstream segment comprises integrators and channels, and the downstream segment includes end users. Understanding the interactions and interdependencies within this ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material suppliers — providing zebrafish and related resources

Technology providers — developing equipment and software for zebrafish research

System integrators — designing and implementing zebrafish research systems

Distributors — supplying zebrafish and related products to research institutions

Service providers — offering maintenance and support services for zebrafish research equipment

End users — conducting zebrafish research in academia and industry

Regulators — establishing standards and guidelines for zebrafish research and use

The flow of value within the Zebrafish for Biotech ecosystem is influenced by various control points, including regulatory bodies and key technology providers. Dependency risks, such as input constraints and standards approvals, can impact the adoption of zebrafish for biotech research. Switching costs and partnerships between stakeholders can also affect the ecosystem's dynamics. Furthermore, the ecosystem may differ by region due to varying regulatory frameworks and research priorities, highlighting the need for a nuanced understanding of the Zebrafish for Biotech ecosystem.

Recent Industry Insights

The Zebrafish for Biotech industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have accelerated innovation, with a notable focus on collaborative research initiatives. Furthermore, the industry has seen a surge in mergers and acquisitions, leading to increased consolidation and expanded capabilities. Additionally, several product and technology launches have enhanced the zebrafish model's applications in biotech research, driving growth and adoption.

Regulatory changes have also played a crucial role in shaping the industry, with updates to guidelines and standards supporting the use of zebrafish in research. A shift in consumer and enterprise trends towards more sustainable and efficient research methods has contributed to the industry's expansion. Moreover, funding rounds and expansions have provided the necessary resources for companies to invest in research and development, further propelling the Zebrafish for Biotech industry trends forward.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Zebrafish for Biotech market outlook. The market attractiveness is high due to the increasing demand for zebrafish in research and development, driven by their unique genetic characteristics and versatility in modeling human diseases. The competitive intensity is moderate, with a mix of established players and new entrants vying for market share.

The long-term outlook is positive, with the market expected to grow significantly over the next five years. The innovation landscape is dynamic, with ongoing research and development focused on improving zebrafish breeding, husbandry, and genomics. However, the demand-supply balance is a key risk factor, as fluctuations in supply can impact research timelines and budgets. Overall, the Zebrafish for Biotech market offers opportunities for growth and innovation, but also presents challenges that must be addressed by industry stakeholders.

11 items

1. Executive Summary

2. Zebrafish for Biotech Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Zebrafish for Biotech Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Zebrafish for Biotech Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Biotechnology Companies

6.1.2. Research Institutes

6.2. Global Zebrafish for Biotech Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Toxicity Testing Services

6.2.2. Transgenesis and Gene Editing Services

6.2.3. Disease Models

6.2.4. Others

6.3. Global Zebrafish for Biotech Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Zebrafish for Biotech Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Zebrafish for Biotech Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Zebrafish for Biotech Market Competition by Key Manufacturers

8.1. Global Zebrafish for Biotech Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Zebrafish for Biotech: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Shanghai Model Organisms Center, Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ZeClinics

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. InVivo Biosystems

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Biobide

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Pentagrit

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Evotec

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Aurigene Pharmaceutical Services

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. ikanbiotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bioreperia

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Hangzhou Hunter Biotechnology Co.,Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. YSY BIOTECH

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Eze-Rinka

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. INVENesis

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. FEIFAN TEST

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Charles River Laboratories

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Zebrafish for Biotech Market

Figure 4: Global Zebrafish for Biotech Market: Drivers

Figure 5: Global Zebrafish for Biotech Market: Challenges

Figure 6: Global Zebrafish for Biotech Market: Trends

Figure 7: Global Zebrafish for Biotech Market: Opportunity

Figure 8: Global Zebrafish for Biotech Market: Restraint

Figure 9: Global Zebrafish for Biotech Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Zebrafish for Biotech Market Value (USD Million) By Region

Figure 15: Global Zebrafish for Biotech Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Zebrafish for Biotech Market Value (USD Million) By Region

Figure 23: Global Zebrafish for Biotech Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Zebrafish for Biotech Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Zebrafish for Biotech Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Zebrafish for Biotech Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Zebrafish for Biotech Market Value (USD Million) By Region

Table 10: Global Zebrafish for Biotech Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Zebrafish for Biotech Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Zebrafish for Biotech Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Zebrafish for Biotech Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Shanghai Model Organisms Center, Inc. Basic Information And Sales Area

Table 31: Shanghai Model Organisms Center, Inc.. Products Portfolio

Table 32: ZeClinics Basic Information And Sales Area

Table 33: ZeClinics. Products Portfolio

Table 34: InVivo Biosystems Basic Information And Sales Area

Table 35: InVivo Biosystems. Products Portfolio

Table 36: Biobide Basic Information And Sales Area

Table 37: Biobide. Products Portfolio

Table 38: Pentagrit Basic Information And Sales Area

Table 39: Pentagrit. Products Portfolio

Table 40: Evotec Basic Information And Sales Area

Table 41: Evotec. Products Portfolio

Table 42: Aurigene Pharmaceutical Services Basic Information And Sales Area

Table 43: Aurigene Pharmaceutical Services. Products Portfolio

Table 44: ikanbiotech Basic Information And Sales Area

Table 45: ikanbiotech. Products Portfolio

Table 46: Bioreperia Basic Information And Sales Area

Table 47: Bioreperia. Products Portfolio

Table 48: Hangzhou Hunter Biotechnology Co.,Ltd. Basic Information And Sales Area

Table 49: Hangzhou Hunter Biotechnology Co.,Ltd.. Products Portfolio

Table 50: YSY BIOTECH Basic Information And Sales Area

Table 51: YSY BIOTECH. Products Portfolio

Table 52: Eze-Rinka Basic Information And Sales Area

Table 53: Eze-Rinka. Products Portfolio

Table 54: INVENesis Basic Information And Sales Area

Table 55: INVENesis. Products Portfolio

Table 56: FEIFAN TEST Basic Information And Sales Area

Table 57: FEIFAN TEST. Products Portfolio

Table 58: Charles River Laboratories Basic Information And Sales Area

Table 59: Charles River Laboratories. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Zebrafish for Biotech Market Value (USD Million) By Region

Table 65: Global Zebrafish for Biotech Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Zebrafish for Biotech Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 million
Revenue forecast in 2033	4.77 million
Growth rate	CAGR of 10.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shanghai Model Organisms Center, Inc.; ZeClinics; InVivo Biosystems; Biobide; Pentagrit; Evotec; Aurigene Pharmaceutical Services; ikanbiotech; Bioreperia; Hangzhou Hunter Biotechnology Co.,Ltd.; YSY BIOTECH; Eze-Rinka; INVENesis; FEIFAN TEST; Charles River Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in genomics and genetic engineering are enabling the use of zebrafish as a model organism for studying human diseases, thereby driving growth in the Zebrafish for Biotech market.

Restraints2 items

Stringent regulations and ethical concerns surrounding the use of animal models in research are hindering the growth of the Zebrafish for Biotech market, impacting the overall growth forecast.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Zebrafish for Biotech Segmentation Breakdown8 items

Application

Biotechnology Companies

Research Institutes

Types

Toxicity Testing Services

Transgenesis and Gene Editing Services

Disease Models

Others

Regional Insights

Loading chart…

Regional Drivers5 items

North America: investments, ecosystem maturity, policies

Europe: demographics, infrastructure, investments

Asia Pacific: adoption, investments, ecosystem growth

Latin America: awareness, investments, research collaborations

Middle East & Africa: awareness, investments, government support

Competitive Landscape

Shanghai Model Organisms Center, Inc. - regional expansion

ZeClinics - innovation pipeline

InVivo Biosystems - vertical integration

Biobide - premium pricing

Pentagrit - OEM tie-ups

Evotec - local manufacturing

Key Zebrafish for Biotech Companies15 items

Shanghai Model Organisms Center, Inc.

ZeClinics

InVivo Biosystems

Biobide

Pentagrit

Evotec

Aurigene Pharmaceutical Services

ikanbiotech

Bioreperia

Hangzhou Hunter Biotechnology Co.,Ltd.

YSY BIOTECH

Eze-Rinka

INVENesis

FEIFAN TEST

Charles River Laboratories

Market Ecosystem

Raw material suppliers — providing zebrafish and related resources

Technology providers — developing equipment and software for zebrafish research

System integrators — designing and implementing zebrafish research systems

Distributors — supplying zebrafish and related products to research institutions

Service providers — offering maintenance and support services for zebrafish research equipment

End users — conducting zebrafish research in academia and industry

Regulators — establishing standards and guidelines for zebrafish research and use

Recent Industry Insights

Analyst Overview

Table of Contents